Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,668,115 papers from all fields of science
Search
Sign In
Create Free Account
UF 021
Known as:
UF-021
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
isopropyl unoprostone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Change in Visual Function after UF-021 Therapy for Retinitis Pigmentosa
A. Hagiwara
,
T. Sugawara
,
Kenjiro Kumagai
,
Ryuta Kimoto
,
S. Yamamoto
2012
Corpus ID: 81991773
2011
2011
Microperimetry Shows Protection of Central Vision in Retinitis Pigmentosa Patients treated with UF-021: a Phase 2 Study (JapicCTI-090748)
S. Yamamoto
,
T. Sugawara
,
+6 authors
Y. Mashima
2011
Corpus ID: 82814546
1994
1994
[Interaction between a prostaglandin F2 alpha derivative, UF-021, and pilocarpine in ocular hypotensive therapy].
T. Yamamoto
,
Q. Chi
,
Y. Kitazawa
Nippon Ganka Gakkai zasshi
1994
Corpus ID: 36347667
We investigated the ocular hypotensive effect of concomitant use of pilocarpine and UF-021, a prostaglandin-related compound, in…
Expand
1994
1994
[Effect of UF-021 on optic nerve head circulation in rabbits].
T. Sugiyama
,
I. Azuma
Nippon Ganka Gakkai zasshi
1994
Corpus ID: 42765884
We studied the effect of UF-021, a prostaglandin-related compound under application as an anti-glaucoma agent, on the circulation…
Expand
1993
1993
[Clinical evaluation of UF-021 ophthalmic solution in glaucoma patients refractory to maximum tolerable therapy].
I. Azuma
Nippon Ganka Gakkai zasshi
1993
Corpus ID: 21345956
UF-021 ophthalmic solution, a novel prostaglandin-related therapeutic agent for glaucoma, was additionally applied to the eyes in…
Expand
1993
1993
Therapeutic effects of UF-021 ophthalmic solution on refractory glaucoma
逸見知弘
1993
Corpus ID: 76606984
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE